{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 414396
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "10003531",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "1",
      "serious": "1",
      "seriousnessdeath": "1",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20140312",
      "fulfillexpeditecriteria": "1",
      "companynumb": "US-CELGENEUS-163-21880-14030209",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "CELGENE",
        "duplicatenumb": "US-CELGENEUS-163-21880-14030209"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "2"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "69",
        "patientonsetageunit": "801",
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Plasma cell myeloma",
            "reactionoutcome": "5"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Respiratory disorder",
            "reactionoutcome": "5"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Arrhythmia",
            "reactionoutcome": "5"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "REVLIMID",
            "drugbatchnumb": "A0350A",
            "drugauthorizationnumb": "021880",
            "drugstructuredosagenumb": "10",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "10 MILLIGRAM",
            "drugdosageform": "Capsules",
            "drugadministrationroute": "048",
            "drugindication": "PLASMA CELL MYELOMA",
            "drugstartdateformat": "102",
            "drugstartdate": "20101103",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA021880"
              ],
              "brand_name": [
                "REVLIMID"
              ],
              "generic_name": [
                "LENALIDOMIDE"
              ],
              "manufacturer_name": [
                "Celgene Corporation"
              ],
              "product_ndc": [
                "59572-402",
                "59572-405",
                "59572-410",
                "59572-415",
                "59572-420",
                "59572-425"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "LENALIDOMIDE"
              ],
              "rxcui": [
                "602910",
                "602912",
                "616114",
                "616116",
                "643712",
                "643714",
                "643720",
                "643722",
                "1242231",
                "1242233",
                "1428947",
                "1429367"
              ],
              "spl_id": [
                "b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb"
              ],
              "spl_set_id": [
                "5fa97bf5-28a2-48f1-8955-f56012d296be"
              ],
              "package_ndc": [
                "59572-402-28",
                "59572-402-00",
                "59572-405-28",
                "59572-405-00",
                "59572-410-28",
                "59572-410-00",
                "59572-415-21",
                "59572-415-00",
                "59572-420-21",
                "59572-420-00",
                "59572-425-21",
                "59572-425-00"
              ],
              "nui": [
                "N0000184014"
              ],
              "pharm_class_epc": [
                "Thalidomide Analog [EPC]"
              ],
              "unii": [
                "F0P408N6V4"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "REVLIMID",
            "drugbatchnumb": "A0350A",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "5-7.5MG",
            "drugdosageform": "Capsules",
            "drugadministrationroute": "048",
            "drugstartdateformat": "610",
            "drugstartdate": "201106",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA021880"
              ],
              "brand_name": [
                "REVLIMID"
              ],
              "generic_name": [
                "LENALIDOMIDE"
              ],
              "manufacturer_name": [
                "Celgene Corporation"
              ],
              "product_ndc": [
                "59572-402",
                "59572-405",
                "59572-410",
                "59572-415",
                "59572-420",
                "59572-425"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "LENALIDOMIDE"
              ],
              "rxcui": [
                "602910",
                "602912",
                "616114",
                "616116",
                "643712",
                "643714",
                "643720",
                "643722",
                "1242231",
                "1242233",
                "1428947",
                "1429367"
              ],
              "spl_id": [
                "b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb"
              ],
              "spl_set_id": [
                "5fa97bf5-28a2-48f1-8955-f56012d296be"
              ],
              "package_ndc": [
                "59572-402-28",
                "59572-402-00",
                "59572-405-28",
                "59572-405-00",
                "59572-410-28",
                "59572-410-00",
                "59572-415-21",
                "59572-415-00",
                "59572-420-21",
                "59572-420-00",
                "59572-425-21",
                "59572-425-00"
              ],
              "nui": [
                "N0000184014"
              ],
              "pharm_class_epc": [
                "Thalidomide Analog [EPC]"
              ],
              "unii": [
                "F0P408N6V4"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "REVLIMID",
            "drugbatchnumb": "A0350A",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "10-15MG",
            "drugdosageform": "Capsules",
            "drugadministrationroute": "048",
            "drugstartdateformat": "610",
            "drugstartdate": "201208",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA021880"
              ],
              "brand_name": [
                "REVLIMID"
              ],
              "generic_name": [
                "LENALIDOMIDE"
              ],
              "manufacturer_name": [
                "Celgene Corporation"
              ],
              "product_ndc": [
                "59572-402",
                "59572-405",
                "59572-410",
                "59572-415",
                "59572-420",
                "59572-425"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "LENALIDOMIDE"
              ],
              "rxcui": [
                "602910",
                "602912",
                "616114",
                "616116",
                "643712",
                "643714",
                "643720",
                "643722",
                "1242231",
                "1242233",
                "1428947",
                "1429367"
              ],
              "spl_id": [
                "b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb"
              ],
              "spl_set_id": [
                "5fa97bf5-28a2-48f1-8955-f56012d296be"
              ],
              "package_ndc": [
                "59572-402-28",
                "59572-402-00",
                "59572-405-28",
                "59572-405-00",
                "59572-410-28",
                "59572-410-00",
                "59572-415-21",
                "59572-415-00",
                "59572-420-21",
                "59572-420-00",
                "59572-425-21",
                "59572-425-00"
              ],
              "nui": [
                "N0000184014"
              ],
              "pharm_class_epc": [
                "Thalidomide Analog [EPC]"
              ],
              "unii": [
                "F0P408N6V4"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "REVLIMID",
            "drugbatchnumb": "A0350A",
            "drugstructuredosagenumb": "10",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "1",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "10 MILLIGRAM",
            "drugdosageform": "Capsules",
            "drugadministrationroute": "048",
            "drugstartdateformat": "610",
            "drugstartdate": "201310",
            "drugenddateformat": "102",
            "drugenddate": "20140301",
            "drugrecurreadministration": "3",
            "openfda": {
              "application_number": [
                "NDA021880"
              ],
              "brand_name": [
                "REVLIMID"
              ],
              "generic_name": [
                "LENALIDOMIDE"
              ],
              "manufacturer_name": [
                "Celgene Corporation"
              ],
              "product_ndc": [
                "59572-402",
                "59572-405",
                "59572-410",
                "59572-415",
                "59572-420",
                "59572-425"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "LENALIDOMIDE"
              ],
              "rxcui": [
                "602910",
                "602912",
                "616114",
                "616116",
                "643712",
                "643714",
                "643720",
                "643722",
                "1242231",
                "1242233",
                "1428947",
                "1429367"
              ],
              "spl_id": [
                "b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb"
              ],
              "spl_set_id": [
                "5fa97bf5-28a2-48f1-8955-f56012d296be"
              ],
              "package_ndc": [
                "59572-402-28",
                "59572-402-00",
                "59572-405-28",
                "59572-405-00",
                "59572-410-28",
                "59572-410-00",
                "59572-415-21",
                "59572-415-00",
                "59572-420-21",
                "59572-420-00",
                "59572-425-21",
                "59572-425-00"
              ],
              "nui": [
                "N0000184014"
              ],
              "pharm_class_epc": [
                "Thalidomide Analog [EPC]"
              ],
              "unii": [
                "F0P408N6V4"
              ]
            }
          }
        ]
      }
    }
  ]
}